English | 繁體

Search in the results

UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation Journal article
Zhou,Jing Bo, Tang,Dongyang, He,Lin, Lin,Shiqi, Lei,Josh Haipeng, Sun,Heng, Xu,Xiaoling, Deng,Chu Xia. Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation[J]. Pharmacological Research, 2023, 194, 106830.
Authors:  Zhou,Jing Bo;  Tang,Dongyang;  He,Lin;  Lin,Shiqi;  Lei,Josh Haipeng; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:9.1/9.0 | Submit date：2023/08/03
Bortezomib (Pubchem Cid: 387447)  Cepharanthine (Pubchem Cid: 10206)  Docetaxel (Taxotere) (Pubchem Cid: 11970251)  Drug Combination Therapy  Flunarizine Dihydrochloride (Pubchem Cid: 5282407)  Lapatinib Ditosylate (Pubchem Cid: 9941095)  Machine Learning  Pazopanib Hydrochloride (Pubchem Cid: 11525740)  Potential Combination Biomarkers  Tamoxifen Citrate (Pubchem Cid: 2733525)  Three-dimensional Tumor Slice Culture  Vatalanib (Pubchem Cid: 151194)  Vincristine (Pubchem Cid: 5978)  Xl-184 (Cabozantinib) (Pubchem Cid: 25102847)  
Tailoring the growth of iron hexacyanoferrates for high-performance cathode of sodium-ion batteries Journal article
Xiang, Jingjing, Hao, Youchen, Gao, Yuting, Ji, Lei, Wang, Li, Sun, Guoxing, Tang, Yuxin, Zhu, Yaofeng, Jiang, Yinzhu. Tailoring the growth of iron hexacyanoferrates for high-performance cathode of sodium-ion batteries[J]. Journal of Alloys and Compounds, 2023, 946, 169284.
Authors:  Xiang, Jingjing;  Hao, Youchen;  Gao, Yuting;  Ji, Lei;  Wang, Li; et al.
Favorite | TC[WOS]:5 TC[Scopus]:5  IF:5.8/5.3 | Submit date：2023/07/19
Good Reversibility  Iron Hexacyanoferrate  Low Vacancy  Sodium Citrate  Sodium-ion Batteries  
Shengui Sansheng San Ameliorates Cerebral Energy Deficiency via Citrate Cycle After Ischemic Stroke Journal article
Cheng Luo, Xiqing Bian, Qian Zhang, Zhenyan Xia, Bowen Liu, Qi Chen, Chienchih Ke, Jian-Lin Wu, Yonghua Zhao. Shengui Sansheng San Ameliorates Cerebral Energy Deficiency via Citrate Cycle After Ischemic Stroke[J]. FRONTIERS IN PHARMACOLOGY, 2019, 10, 386.
Authors:  Cheng Luo;  Xiqing Bian;  Qian Zhang;  Zhenyan Xia;  Bowen Liu; et al.
Adobe PDF | Favorite | TC[WOS]:25 TC[Scopus]:19  IF:4.4/5.0 | Submit date：2020/04/14
Cerebral Energy Deficiency  Citrate Cycle  Diaaa Derivatization-uhplc-q-tof/ms  Ischemic Stroke  Shengui Sansheng San  
Identification of a new high-molecular-weight Fe-citrate species at low citrate-to-Fe molar ratios: Impact on arsenic removal with ferric hydroxide Journal article
Zhang, Ping, Zhang, Nan, Li, Zhejun, Yean, Sujin, Li, Hualin, Shipley, Heather J., Kan, Amy T., Chen, Wei, Tomson, Mason B.. Identification of a new high-molecular-weight Fe-citrate species at low citrate-to-Fe molar ratios: Impact on arsenic removal with ferric hydroxide[J]. CHEMOSPHERE, 2018, 212, 50-55.
Authors:  Zhang, Ping;  Zhang, Nan;  Li, Zhejun;  Yean, Sujin;  Li, Hualin; et al.
Favorite | TC[WOS]:2 TC[Scopus]:3  IF:8.1/7.7 | Submit date：2018/10/30
Arsenic Removal  Citrate  Ferric Hydroxide  Molar Ratio  
Identification of a new high-molecular-weight Fe−citrate species at low citrate-to-Fe molar ratios: Impact on arsenic removal with ferric hydroxide Journal article
Zhang,Ping, Zhang,Nan, Li,Zhejun, Yean,Sujin, Li,Hualin, Shipley,Heather J., Kan,Amy T., Chen,Wei, Tomson,Mason B.. Identification of a new high-molecular-weight Fe−citrate species at low citrate-to-Fe molar ratios: Impact on arsenic removal with ferric hydroxide[J]. Chemosphere, 2018, 212, 50-55.
Authors:  Zhang,Ping;  Zhang,Nan;  Li,Zhejun;  Yean,Sujin;  Li,Hualin; et al.
Favorite | TC[WOS]:2 TC[Scopus]:3 | Submit date：2019/05/21
Arsenic Removal  Citrate  Ferric Hydroxide  Molar Ratio  
Furanodiene alters mitochondrial function in doxorubicin-resistant MCF-7 human breast cancer cells in an AMPK-dependent manner Journal article
Zhong Z.-F., Tan W., Qiang W.W., Scofield V.L., Tian K., Wang C.-M., Qiang W.-A., Wang Y.-T.. Furanodiene alters mitochondrial function in doxorubicin-resistant MCF-7 human breast cancer cells in an AMPK-dependent manner[J]. Molecular BioSystems, 2016, 12(5), 1626.
Authors:  Zhong Z.-F.;  Tan W.;  Qiang W.W.;  Scofield V.L.;  Tian K.; et al.
Favorite | TC[WOS]:31 TC[Scopus]:36 | Submit date：2018/10/31
Atp-citrate Lyase  Activated Protein-kinase  Double-strand Breaks  In-vitro  Multidrug-resistance  Drug-resistance  Metabolic-disorders  Signaling Pathway  Cellular-energy  Natural-product